{"id":4063,"date":"2021-10-26T01:50:36","date_gmt":"2021-10-26T01:50:36","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=4063"},"modified":"2023-08-29T17:51:39","modified_gmt":"2023-08-29T17:51:39","slug":"amplia-therapeutics-secures-renowned-oncology-drug-development-expert-clinical-advisor","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=4063","title":{"rendered":"Amplia Therapeutics\u8058\u8bf7\u8457\u540d\u80bf\u7624\u836f\u7269\u5f00\u53d1\u4e13\u5bb6\u62c5\u4efb\u4e34\u5e8a\u987e\u95ee"},"content":{"rendered":"<p>Amplia Therapeutics (ASX: ATX)\u5df2\u4efb\u547dDr Jos\u00e9 Iglesias\u4e3a\u80f0\u817a\u764c\u6cbb\u7597\u7684\u4e34\u5e8a\u987e\u95ee\uff0c\u534f\u52a9\u5176\u764c\u75c7\u548c\u808c\u7624\u836f\u7269\u7684\u5f00\u53d1\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u6307\u51fa\uff0cDr Iglesias\u8d1f\u8d23\u5f00\u53d1Abraxane\uff0c\u8fd9\u662f\u76ee\u524d\u665a\u671f\u80f0\u817a\u764c\u6cbb\u7597\u6807\u51c6\u7684\u57fa\u77f3\u3002<\/p>\n<p>\u8be5\u836f\u7269\u4e5f\u662fAmplia\u7684\u5c40\u7076\u7c98\u8fde\u6fc0\u9176\u6291\u5236\u5242AMP945\u6cbb\u7597\u7684\u9996\u4e2a\u4e34\u5e8a\u9002\u5e94\u75c7\u3002<\/p>\n<p>Amplia\u8868\u793a\uff0c\u8ba9Iglesias\u535a\u58eb\u62c5\u4efb\u4e34\u5e8a\u987e\u95ee\u5c06\u80fd\u83b7\u5f97\u4ed6\u7684\u201c\u5e7f\u6cdb\u7ecf\u9a8c\u201d\uff0c\u5e76\u534f\u52a9\u5f00\u53d1\u65b0\u7684\u80bf\u7624\u836f\u7269\u3002<\/p>\n<p>Dr Iglesias\u5728\u5236\u836f\u884c\u4e1a\u6709\u8d85\u8fc730\u5e74\u7684\u7ecf\u9a8c\uff0c\u4e13\u6ce8\u4e8e\u5f00\u53d1\u65b0\u7684\u80bf\u7624\u836f\u7269\u3002<\/p>\n<p>Amplia\u9996\u5e2d\u6267\u884c\u5b98\u517c\u8463\u4e8b\u603b\u7ecf\u7406John Lambert\u8868\u793a:\u201cDr Iglesias\u5728\u80bf\u7624\u65b0\u836f\u4e34\u5e8a\u5f00\u53d1\u65b9\u9762\u7684\u4e30\u5bcc\u7ecf\u9a8c\u5c06\u5bf9\u6211\u4eec\u660e\u5e74\u5e74\u521d\u5f00\u59cb\u5728\u80f0\u817a\u764c\u60a3\u8005\u4e2d\u5f00\u5c55AMP945\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5177\u6709\u91cd\u8981\u610f\u4e49\u3002\u201d<\/p>\n<p>\u201cDr Iglesias\u5728\u9886\u5bfc\u5f53\u524d\u533b\u7597\u6807\u51c6\u53d1\u5c55\u65b9\u9762\u7684\u4e30\u5bcc\u7ecf\u9a8c\uff0c\u6211\u4eec\u8ba1\u5212\u5c06AMP945\u52a0\u5165\u5176\u4e2d\uff0c\u8fd9\u5c06\u7279\u522b\u76f8\u5173\uff0c\u5e76\u5c06\u6781\u5927\u5730\u589e\u5f3a\u6211\u4eec\u8fdb\u884c\u8bd5\u9a8c\u548c\u89e3\u91ca\u7d27\u6025\u4e34\u5e8a\u6570\u636e\u7684\u80fd\u529b\u3002\u201d<\/p>\n<h2>\u6025\u9700\u80f0\u817a\u764c\u6cbb\u7597<\/h2>\n<p>\u5728\u8c08\u5230\u4ed6\u5728Amplia\u7684\u65b0\u89d2\u8272\u65f6\uff0cDr Iglesias\u8868\u793a\uff0c\u4ed6\u201c\u975e\u5e38\u9ad8\u5174\u201d\u80fd\u591f\u4ece\u4e8b\u6cbb\u7597\u80f0\u817a\u764c\u7684\u201c\u4ee4\u4eba\u5174\u594b\u7684\u65b0\u65b9\u6cd5\u201d\u7684\u7814\u7a76\u3002<\/p>\n<p>\u4ed6\u6307\u51fa\uff0c\u80f0\u817a\u764c\u4ecd\u7136\u662f\u4e00\u79cd\u201c\u6bc1\u706d\u6027\u7684\u201d\u548c\u201c\u7ba1\u7406\u4e0d\u5584\u7684\u201d\u75be\u75c5\uff0c\u201c\u8feb\u5207\u9700\u8981\u201d\u65b0\u7684\u6cbb\u7597\u65b9\u6cd5\uff0c\u5305\u62ecAmplia\u7684AMP945\u3002<\/p>\n<p>\u80f0\u817a\u764c\u662f\u6700\u81f4\u547d\u7684\u764c\u75c7\u4e4b\u4e00\uff0c5\u5e74\u751f\u5b58\u7387\u4e3a5-10%\u3002<\/p>\n<p>\u552f\u4e00\u53ef\u80fd\u7684\u6cbb\u7597\u65b9\u6cd5\u662f\u624b\u672f\u5207\u9664\uff0c\u4f46\u53ea\u670920%\u7684\u60a3\u8005\u7b26\u5408\u8fd9\u4e00\u6761\u4ef6\u3002\u5176\u4f59\u60a3\u8005\u8981\u4e48\u60a3\u6709\u5c40\u90e8\u4e0d\u53ef\u5207\u9664\u7684\u75be\u75c5\uff0c\u8981\u4e48\u60a3\u6709\u8f6c\u79fb\u6027\u75be\u75c5\u3002<\/p>\n<p>\u4e0d\u80fd\u8fdb\u884c\u624b\u672f\u7684\u60a3\u8005\u7684\u4e00\u7ebf\u6cbb\u7597\u662f\u4f7f\u7528\u5409\u897f\u4ed6\u6ee8\/Abraxane\u6216FOLFIRINOX\u5316\u7597\u3002<\/p>\n<p>\u6b64\u5916\uff0c\u53ea\u670940-50%\u7684\u4e00\u7ebf\u60a3\u8005\u80fd\u591f\u63a5\u53d7\u4e8c\u7ebf\u6cbb\u7597\uff0c\u76ee\u524d\u8fd8\u6ca1\u6709\u9488\u5bf9\u4e8c\u7ebf\u60a3\u8005\u7684\u6807\u51c6\u6cbb\u7597\u65b9\u6cd5\u3002<\/p>\n<p>Amplia\u6b63\u5728\u5f00\u53d1FOK\u6291\u5236\u5242\uff0c\u4ee5\u7834\u574f\u764c\u75c7\u9632\u5fa1\u673a\u5236\uff0c\u5e76\u4f7f\u764c\u75c7\u5bf9\u836f\u7269\u66f4\u654f\u611f\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Amplia Therapeutics (ASX: ATX)\u5df2\u4efb\u547dDr Jos\u00e9 Iglesias\u4e3a\u80f0\u817a\u764c\u6cbb\u7597\u7684\u4e34\u5e8a\u987e\u95ee\uff0c\u534f\u52a9\u5176\u764c\u75c7\u548c\u808c\u7624\u836f\u7269\u7684\u5f00\u53d1\u3002 \u8be5\u516c\u53f8\u6307\u51fa\uff0cDr Iglesias\u8d1f\u8d23\u5f00\u53d1Abraxane\uff0c\u8fd9\u662f\u76ee\u524d\u665a\u671f\u80f0\u817a\u764c\u6cbb\u7597\u6807\u51c6\u7684\u57fa\u77f3\u3002 \u8be5\u836f\u7269\u4e5f\u662fAmplia\u7684\u5c40\u7076\u7c98\u8fde\u6fc0\u9176\u6291\u5236\u5242AMP945\u6cbb\u7597\u7684\u9996\u4e2a\u4e34\u5e8a\u9002\u5e94\u75c7\u3002 Amplia\u8868\u793a\uff0c\u8ba9Iglesias\u535a\u58eb\u62c5\u4efb\u4e34\u5e8a\u987e\u95ee\u5c06\u80fd\u83b7\u5f97\u4ed6\u7684\u201c\u5e7f\u6cdb\u7ecf\u9a8c\u201d\uff0c\u5e76\u534f\u52a9\u5f00\u53d1\u65b0\u7684\u80bf\u7624\u836f\u7269\u3002 Dr Iglesias\u5728\u5236\u836f\u884c\u4e1a\u6709\u8d85\u8fc730\u5e74\u7684\u7ecf\u9a8c\uff0c\u4e13\u6ce8\u4e8e\u5f00\u53d1\u65b0\u7684\u80bf\u7624\u836f\u7269\u3002 Amplia\u9996\u5e2d\u6267\u884c\u5b98\u517c\u8463\u4e8b\u603b\u7ecf\u7406John Lambert\u8868\u793a:\u201cDr Iglesias\u5728\u80bf\u7624\u65b0\u836f\u4e34\u5e8a\u5f00\u53d1\u65b9\u9762\u7684\u4e30\u5bcc\u7ecf\u9a8c\u5c06\u5bf9\u6211\u4eec\u660e\u5e74\u5e74\u521d\u5f00\u59cb\u5728\u80f0\u817a\u764c\u60a3\u8005\u4e2d\u5f00\u5c55AMP945\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5177\u6709\u91cd\u8981\u610f\u4e49\u3002\u201d \u201cDr Iglesias\u5728\u9886\u5bfc\u5f53\u524d\u533b\u7597\u6807\u51c6\u53d1\u5c55\u65b9\u9762\u7684\u4e30\u5bcc\u7ecf\u9a8c\uff0c\u6211\u4eec\u8ba1\u5212\u5c06AMP945\u52a0\u5165\u5176\u4e2d\uff0c\u8fd9\u5c06\u7279\u522b\u76f8\u5173\uff0c\u5e76\u5c06\u6781\u5927\u5730\u589e\u5f3a\u6211\u4eec\u8fdb\u884c\u8bd5\u9a8c\u548c\u89e3\u91ca\u7d27\u6025\u4e34\u5e8a\u6570\u636e\u7684\u80fd\u529b\u3002\u201d \u6025\u9700\u80f0\u817a\u764c\u6cbb\u7597 \u5728\u8c08\u5230\u4ed6\u5728Amplia\u7684\u65b0\u89d2\u8272\u65f6\uff0cDr Iglesias\u8868\u793a\uff0c\u4ed6\u201c\u975e\u5e38\u9ad8\u5174\u201d\u80fd\u591f\u4ece\u4e8b\u6cbb\u7597\u80f0\u817a\u764c\u7684\u201c\u4ee4\u4eba\u5174\u594b\u7684\u65b0\u65b9\u6cd5\u201d\u7684\u7814\u7a76\u3002 \u4ed6\u6307\u51fa\uff0c\u80f0\u817a\u764c\u4ecd\u7136\u662f\u4e00\u79cd\u201c\u6bc1\u706d\u6027\u7684\u201d\u548c\u201c\u7ba1\u7406\u4e0d\u5584\u7684\u201d\u75be\u75c5\uff0c\u201c\u8feb\u5207\u9700\u8981\u201d\u65b0\u7684\u6cbb\u7597\u65b9\u6cd5\uff0c\u5305\u62ecAmplia\u7684AMP945\u3002 \u80f0\u817a\u764c\u662f\u6700\u81f4\u547d\u7684\u764c\u75c7\u4e4b\u4e00\uff0c5\u5e74\u751f\u5b58\u7387\u4e3a5-10%\u3002 \u552f\u4e00\u53ef\u80fd\u7684\u6cbb\u7597\u65b9\u6cd5\u662f\u624b\u672f\u5207\u9664\uff0c\u4f46\u53ea\u670920%\u7684\u60a3\u8005\u7b26\u5408\u8fd9\u4e00\u6761\u4ef6\u3002\u5176\u4f59\u60a3\u8005\u8981\u4e48\u60a3\u6709\u5c40\u90e8\u4e0d\u53ef\u5207\u9664\u7684\u75be\u75c5\uff0c\u8981\u4e48\u60a3\u6709\u8f6c\u79fb\u6027\u75be\u75c5\u3002 \u4e0d\u80fd\u8fdb\u884c\u624b\u672f\u7684\u60a3\u8005\u7684\u4e00\u7ebf\u6cbb\u7597\u662f\u4f7f\u7528\u5409\u897f\u4ed6\u6ee8\/Abraxane\u6216FOLFIRINOX\u5316\u7597\u3002 \u6b64\u5916\uff0c\u53ea\u670940-50%\u7684\u4e00\u7ebf\u60a3\u8005\u80fd\u591f\u63a5\u53d7\u4e8c\u7ebf\u6cbb\u7597\uff0c\u76ee\u524d\u8fd8\u6ca1\u6709\u9488\u5bf9\u4e8c\u7ebf\u60a3\u8005\u7684\u6807\u51c6\u6cbb\u7597\u65b9\u6cd5\u3002 Amplia\u6b63\u5728\u5f00\u53d1FOK\u6291\u5236\u5242\uff0c\u4ee5\u7834\u574f\u764c\u75c7\u9632\u5fa1\u673a\u5236\uff0c\u5e76\u4f7f\u764c\u75c7\u5bf9\u836f\u7269\u66f4\u654f\u611f\u3002<\/p>\n","protected":false},"author":3,"featured_media":13619,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[58],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Amplia Therapeutics\u8058\u8bf7\u8457\u540d\u80bf\u7624\u836f\u7269\u5f00\u53d1\u4e13\u5bb6\u62c5\u4efb\u4e34\u5e8a\u987e\u95ee<\/title>\n<meta name=\"description\" content=\"Amplia Therapeutics (ASX: ATX)\u5df2\u4efb\u547dDr Jos\u00e9 Iglesias\u4e3a\u80f0\u817a\u764c\u6cbb\u7597\u7684\u4e34\u5e8a\u987e\u95ee\uff0c\u534f\u52a9\u5176\u764c\u75c7\u548c\u808c\u7624\u836f\u7269\u7684\u5f00\u53d1\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amplia Therapeutics\u8058\u8bf7\u8457\u540d\u80bf\u7624\u836f\u7269\u5f00\u53d1\u4e13\u5bb6\u62c5\u4efb\u4e34\u5e8a\u987e\u95ee\" \/>\n<meta property=\"og:description\" content=\"Amplia Therapeutics (ASX: ATX)\u5df2\u4efb\u547dDr Jos\u00e9 Iglesias\u4e3a\u80f0\u817a\u764c\u6cbb\u7597\u7684\u4e34\u5e8a\u987e\u95ee\uff0c\u534f\u52a9\u5176\u764c\u75c7\u548c\u808c\u7624\u836f\u7269\u7684\u5f00\u53d1\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-secures-renowned-oncology-drug-development-expert-clinical-advisor\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-26T01:50:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:51:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Amplia-Therapeutics-ASX-ATX-clinical-advisor-Jose\u0301-Iglesias-oncology-drugs-cancer-fibrosis.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-secures-renowned-oncology-drug-development-expert-clinical-advisor\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-secures-renowned-oncology-drug-development-expert-clinical-advisor\/\",\"name\":\"Amplia Therapeutics\u8058\u8bf7\u8457\u540d\u80bf\u7624\u836f\u7269\u5f00\u53d1\u4e13\u5bb6\u62c5\u4efb\u4e34\u5e8a\u987e\u95ee\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-10-26T01:50:36+00:00\",\"dateModified\":\"2023-08-29T17:51:39+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"Amplia Therapeutics (ASX: ATX)\u5df2\u4efb\u547dDr Jos\u00e9 Iglesias\u4e3a\u80f0\u817a\u764c\u6cbb\u7597\u7684\u4e34\u5e8a\u987e\u95ee\uff0c\u534f\u52a9\u5176\u764c\u75c7\u548c\u808c\u7624\u836f\u7269\u7684\u5f00\u53d1\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-secures-renowned-oncology-drug-development-expert-clinical-advisor\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-secures-renowned-oncology-drug-development-expert-clinical-advisor\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-secures-renowned-oncology-drug-development-expert-clinical-advisor\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amplia Therapeutics\u8058\u8bf7\u8457\u540d\u80bf\u7624\u836f\u7269\u5f00\u53d1\u4e13\u5bb6\u62c5\u4efb\u4e34\u5e8a\u987e\u95ee\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Amplia Therapeutics\u8058\u8bf7\u8457\u540d\u80bf\u7624\u836f\u7269\u5f00\u53d1\u4e13\u5bb6\u62c5\u4efb\u4e34\u5e8a\u987e\u95ee","description":"Amplia Therapeutics (ASX: ATX)\u5df2\u4efb\u547dDr Jos\u00e9 Iglesias\u4e3a\u80f0\u817a\u764c\u6cbb\u7597\u7684\u4e34\u5e8a\u987e\u95ee\uff0c\u534f\u52a9\u5176\u764c\u75c7\u548c\u808c\u7624\u836f\u7269\u7684\u5f00\u53d1\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Amplia Therapeutics\u8058\u8bf7\u8457\u540d\u80bf\u7624\u836f\u7269\u5f00\u53d1\u4e13\u5bb6\u62c5\u4efb\u4e34\u5e8a\u987e\u95ee","og_description":"Amplia Therapeutics (ASX: ATX)\u5df2\u4efb\u547dDr Jos\u00e9 Iglesias\u4e3a\u80f0\u817a\u764c\u6cbb\u7597\u7684\u4e34\u5e8a\u987e\u95ee\uff0c\u534f\u52a9\u5176\u764c\u75c7\u548c\u808c\u7624\u836f\u7269\u7684\u5f00\u53d1\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-secures-renowned-oncology-drug-development-expert-clinical-advisor\/","og_site_name":"smallcapsCN","article_published_time":"2021-10-26T01:50:36+00:00","article_modified_time":"2023-08-29T17:51:39+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Amplia-Therapeutics-ASX-ATX-clinical-advisor-Jose\u0301-Iglesias-oncology-drugs-cancer-fibrosis.jpg","type":"image\/jpeg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-secures-renowned-oncology-drug-development-expert-clinical-advisor\/","url":"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-secures-renowned-oncology-drug-development-expert-clinical-advisor\/","name":"Amplia Therapeutics\u8058\u8bf7\u8457\u540d\u80bf\u7624\u836f\u7269\u5f00\u53d1\u4e13\u5bb6\u62c5\u4efb\u4e34\u5e8a\u987e\u95ee","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-10-26T01:50:36+00:00","dateModified":"2023-08-29T17:51:39+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"Amplia Therapeutics (ASX: ATX)\u5df2\u4efb\u547dDr Jos\u00e9 Iglesias\u4e3a\u80f0\u817a\u764c\u6cbb\u7597\u7684\u4e34\u5e8a\u987e\u95ee\uff0c\u534f\u52a9\u5176\u764c\u75c7\u548c\u808c\u7624\u836f\u7269\u7684\u5f00\u53d1\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-secures-renowned-oncology-drug-development-expert-clinical-advisor\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-secures-renowned-oncology-drug-development-expert-clinical-advisor\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-secures-renowned-oncology-drug-development-expert-clinical-advisor\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Amplia Therapeutics\u8058\u8bf7\u8457\u540d\u80bf\u7624\u836f\u7269\u5f00\u53d1\u4e13\u5bb6\u62c5\u4efb\u4e34\u5e8a\u987e\u95ee"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4063"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4063"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4063\/revisions"}],"predecessor-version":[{"id":13618,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4063\/revisions\/13618"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/13619"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4063"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4063"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4063"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}